10-Q/A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q/A

(Amendment No. 1)

 

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2018

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission File Number: 001-38718

 

 

Federal Life Group, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Pennsylvania   82-4944172

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

3750 West Deerfield Road

Riverwoods, Illinois 60015

(Address of principal executive offices, including zip code)

(847) 520-1900

(Registrant’s telephone number, including area code)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☐    No  ☒

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer      Accelerated filer  
Non-accelerated filer      Smaller reporting company  
Emerging growth company       

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  ☒

APPLICABLE TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

As of January 22, 2019, there were 3,530,250 shares of the registrant’s common stock, $.01 par value, outstanding.

 

 

 


EXPLANATORY NOTE

This Amendment No. 1 (this “Amendment”) to Federal Life Group Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2018 which was originally filed on December 26, 2018 (the “Original Filing”) is being filed for the purpose of furnishing Exhibit 101 to the Form 10-Q in accordance with Rule 405 of Regulation S-T and to correct two immaterial errors included in the consolidated financial statements.

Exhibit 101 to this Amendment No. 1 provides the consolidated financial statements and related notes from the Form 10-Q formatted in XBRL (eXtensible Business Reporting Language). This Amendment is being filed within the time period provided by Rule 405(a)(2) of Regulation S-T.

In addition, this Amendment corrects two immaterial errors contained in the Original Filing.

The first appeared in Item 1 of the Original Filing, in the Liabilities section of the Consolidated Balance Sheet. The line item entitled “Other Liabilities” as at September 30, 2018 should appear as $999 thousand rather than $2,049 thousand. The total Liabilities figure remains unchanged. Below is the corrected Consolidated Balance Sheet:

FEDERAL LIFE GROUP, INC.

CONSOLIDATED BALANCE SHEETS

(Dollars in thousands)

 

     Predecessor     Predecessor  
     9/30/2018     12/31/2017  
     (unaudited)        

Assets

    

Investments

    

Securities available for sale, at fair value:

    

Fixed maturities (amortized cost; 2018, $184,995; 2017, $183,432)

   $ 181,497     $ 188,452  

Equity securities

     6,620       6,209  

Policy loans

     9,599       9,852  

Derivative instruments, at fair value

     517       395  
  

 

 

   

 

 

 

Total investments

     198,233       204,908  

Cash and cash equivalents

     3,466       4,085  

Real estate, property and equipment, net

     2,172       2,151  

Accrued investment income

     1,999       1,886  

Accounts receivable

     2,489       538  

Reinsurance recoverables

     3,571       3,727  

Prepaid reinsurance premiums

     1,387       1,358  

Deferred policy acquisition costs, net

     13,617       12,179  

Deferred sales inducement costs, net

     1,192       867  

Deferred tax asset, net

     495       458  

Other assets

     249       202  

Separate account asset

     24,434       24,779  
  

 

 

   

 

 

 

Total Assets

     253,304       257,138  
  

 

 

   

 

 

 

Liabilities

    

Policy liabilities and accruals

    

Policyholder account balance

     115,142       109,823  

Future life policy benefits

     72,227       71,927  

Future accident and health policy benefits

     343       386  

Reserve for deposit type contracts

     10,885       10,850  

Other policyholder funds

     3,099       1,970  

Unearned revenue

     1,366       1,387  

Deferred reinsurance settlements

     2,727       2,949  

Taxes payable

     6       7  

Promissory note

     1,050    

Other liabilities

     999       1,703  

Separate account liability

     24,434       24,779  
  

 

 

   

 

 

 

Total Liabilities

     232,278       225,781  
  

 

 

   

 

 

 

Equity

    

Retained earnings

     23,165       26,600  

Accumulated other comprehensive income (loss)

     (2,139     4,757  
  

 

 

   

 

 

 

Total Equity

     21,026       31,357  
  

 

 

   

 

 

 

Total Liabilities and Equity

   $ 253,304     $ 257,138  
  

 

 

   

 

 

 

See full notes to unaudited consolidated financial statements contained in the Original Filing, as defined herein.

The second appeared in Note 6 to the consolidated financial statements on page 18 in the table entitled “Predecessor—Recurring Fair Value Measurements at December 31, 2017…” In that table the column headed “Significant Other Observable Inputs (Level 2)” should total $184,290 thousand rather than $179,219 thousand. Below is the corrected table:

 

     Predecessor
Recurring Fair Value Measurements
at December 31, 2017 Using:
 

Description

   Fair
Values
     Quoted
Prices
in Active
Markets
for
Identical
Assets
(Level 1)
     Significant
Other
Observable

Inputs
(Level 2)
     Significant
Unobservable
Inputs
(Level 3)
 
     (Dollars in thousands)  

Fixed maturity securities:

           

U.S. government

   $ 4,162      $ 4,162      $ —        $ —    

States, political subdivisions, other

     27,614        —          27,614     

Corporate

     109,395        —          109,395     

Residential mortgage-backed securities

     43,086        —          43,086     

Commercial mortgage-backed securities

     4,195        —          4,195     
  

 

 

    

 

 

    

 

 

    

 

 

 

Total fixed maturities

     188,452        4,162        184,290     

Equities

     6,209        4,027        —          2,182  

Derivative instruments

     395        395        —          —    

Cash equivalents (1)

     4,085        4,085        

Separate accounts (2)

     24,779        24,779        
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 223,920      $ 37,448      $ 184,290      $ 2,182  
  

 

 

    

 

 

    

 

 

    

 

 

 

No other changes have been made to the Original Filing. This Amendment does not reflect subsequent events occurring after the date of the Original Filing.


Item 6. Exhibits

 

Exhibit No   Description

3.1*

  Amended and Restated Articles of Incorporation of Federal Life Group, Inc.

3.2*

  Bylaws of Federal Life Group, Inc.

31.1**

  Certification of Chief Executive Officer, pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended

31.2**

  Certification of Chief Financial Officer, pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended

32.1***

  Certification of Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2***

  Certification of Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS**

  XBRL Instance Document.

101.SCH**

  XBRL Taxonomy Extension Schema Document.

101.CAL**

  XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF**

  XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB**

  XBRL Taxonomy Extension Label Linkbase Document.

101.PRE**

  XBRL Taxonomy Extension Presentation Linkbase Document.

 

*

Incorporated by reference from the Company’s Form S-1 filed with the SEC on October 11, 2018.

**

Filed herewith.

***

Furnished herewith (such certification shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, except to the extent that the Company specifically incorporates it by reference).


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

FEDERAL LIFE GROUP, INC.
By:   /s/ William S. Austin
  William S. Austin
  President and Chief Executive Officer

January 22, 2019

 

EX-31.1

Exhibit 31.1

CERTIFICATION

I, William S. Austin, certify that:

 

1.

I have reviewed this quarterly report on Form 10-Q/A of Federal Life Group, Inc. (the “registrant”);

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as define in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a)

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b)

designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c)

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report, based on such evaluations; and

 

  d)

disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal controls over financial reporting.

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the Audit committee of registrant’s Board of Directors:

 

  a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: January 22, 2019

 

/s/ William S. Austin
William S. Austin
Chief Executive Officer, Federal Life Group, Inc.

 

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Anders Raaum, certify that:

 

1.

I have reviewed this quarterly report on Form 10-Q/A of Federal Life Group, Inc. (the “registrant”);

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a)

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b)

designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c)

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report, based on such evaluations; and

 

  d)

disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the Audit Committee of registrant’s Board of Directors:

 

  a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: January 22, 2019

 

/s/ Anders Raaum
Anders Raaum
Chief Financial Officer, Federal Life Group, Inc.

 

EX-32.1

Exhibit 32.1

Federal Life Group, Inc.

Certification of Periodic Financial Report

Pursuant to 18 U.S.C. Section 1350

as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

The undersigned officer of Federal Life Group, Inc. (“FLG”) certifies, to his knowledge and solely for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q/A of FLG for the period ended September 30, 2018 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in the Form 10-Q/A fairly presents, in all material respects, the financial condition and results of operations of FLG.

 

Dated: January 22, 2019     By:   /s/ William S. Austin
      William S. Austin
      Chief Executive Officer, Federal Life Group, Inc.

 

EX-32.2

Exhibit 32.2

Federal Life Group, Inc.

Certification of Periodic Financial Report

Pursuant to 18 U.S.C. Section 1350

as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

The undersigned officer of Federal Life Group, Inc. (“FLG”) certifies, to his knowledge and solely for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q/A of FLG for the period ended September 30, 2018 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in the Form 10-Q/A fairly presents, in all material respects, the financial condition and results of operations of FLG.

 

Dated: January 22, 2019     By:   /s/ Anders Raaum
      Anders Raaum
      Chief Financial Officer, Federal Life Group, Inc.